MRC1 and cancer: Ferumoxytol did enhance CD86 expression and TNF-α production and downregulated CD206 with decreased IL-10, while our nanoparticles HA-man@Fe3O4 outperformed it in macrophage repolarizing with the same amount of iron, suggesting our nanoadjuvant might be efficient in cancer vaccine treatment with HA and mannose dual modification.